Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Abstract Text:

    PURPOSE: To evaluate clinical features and risks for transformation of conjunctival primary acquired melanosis (PAM) into melanoma. METHODS: Retrospective chart review and Kaplan-Meier estimates of times to PAM enlargement, recurrence, and transformation into melanoma. MAIN OUTCOME MEASURES: PAM enlargement, recurrence, and transformation into melanoma. RESULTS: The mean patient age at diagnosis of PAM was 56 years; 62% were female and 96% Caucasian. The conjunctival quadrant(s) affected by PAM and its extent in clock hours were recorded. Initial management included observation in 62%, biopsy combined with cryotherapy in 34%, and other methods in 4%. Of PAM that was observed, Kaplan-Meier estimates at 10 years revealed PAM enlargement in 35% and transformation into melanoma in 12%. Of those that underwent incisional or excisional biopsy, 10-year estimates of PAM recurrence and transformation into melanoma were 58% and 11%, respectively. Progression to melanoma occurred in 0% of PAM without atypia, 0% of PAM with mild atypia, and 13% of PAM with severe atypia. Multivariable analysis revealed that the most significant factor for both PAM recurrence and progression to melanoma was extent of PAM in clock hours. CONCLUSION: PAM without atypia or with mild atypia shows 0% progression into melanoma, whereas PAM with severe atypia shows progression into melanoma in 13%. The greater the extent of PAM in clock hours, the greater the risk for transformation into melanoma.

    Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Transactions of the American Ophthalmological Soci

    VOLUME: 105

    Page Numbers: 61-71; discussion 71-2

    Journal Abbreviation:

    ISSN: 1545-6110

    DAY: 22

    MONTH: 04

    YEAR: 2007

    Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7506106

    Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

    AFFILIATION: Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Trans Am Ophthalmol Soc

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Primary acquired melanosis of the conjunctiva: experience with 311 eyes Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News